Proteostasis in Aging

Proteostasis in Aging sits within aging biology and addresses loss of proteostasis, aggregation, and chaperone networks in aged cells. The page below sketches the conceptual scope of the area, the methodological tools it relies on, and the recent literature anchoring its current frontier.

The area organises around a small number of recurring axes: scope (what biological scales the work spans), method (the dominant experimental or computational tools), data regime (what kinds of measurements are now routine vs. still frontier), and open questions (what the field cannot yet do reliably). The sources below cover different combinations of these axes.

Frontier results

A primary recent reference for this area is Adapting proteostasis for disease intervention (Balch et al., 2008), which contributes to the methodological or empirical conversation that defines the current frontier of proteostasis in aging. It illustrates the kind of question the field is actively pursuing — the specific technical claim, the dataset or system on which it was validated, and the way subsequent work builds on it.

Supporting context

Supporting context comes from The hallmarks of aging (Lopez et al., 2013), cited here as a representative entry into adjacent results that reinforce the framing of proteostasis in aging without being the central methodological claim.

Open questions

Open questions in proteostasis in aging cluster around scaling current methods to larger systems, integrating measurements across modalities, and producing predictive rather than descriptive models. The references above mark the work that the next iteration of this page should engage with in more specific detail.